Dr. Martens plc (LON:DOCS – Get Free Report) fell 1% on Friday . The company traded as low as GBX 55.55 ($0.72) and last traded at GBX 56.10 ($0.73). 979,891 shares were traded during trading, a decline of 54% from the average session volume of 2,113,053 shares. The stock had previously closed at GBX 56.65 ($0.74).
Dr. Martens Stock Down 1.0 %
The stock has a market capitalization of £539.52 million, a price-to-earnings ratio of 801.43, a P/E/G ratio of 6.40 and a beta of 0.11. The business has a 50-day moving average of GBX 58.54 and a 200-day moving average of GBX 70.33. The company has a debt-to-equity ratio of 129.55, a quick ratio of 1.13 and a current ratio of 2.85.
Insiders Place Their Bets
In related news, insider Andrew Harrison purchased 58,220 shares of the company’s stock in a transaction on Tuesday, September 24th. The stock was acquired at an average cost of GBX 52 ($0.68) per share, for a total transaction of £30,274.40 ($39,409.53). In related news, insider Andrew Harrison acquired 58,220 shares of the stock in a transaction that occurred on Tuesday, September 24th. The stock was purchased at an average price of GBX 52 ($0.68) per share, with a total value of £30,274.40 ($39,409.53). Also, insider Kenny Wilson bought 30,000 shares of the company’s stock in a transaction that occurred on Thursday, September 26th. The stock was bought at an average price of GBX 55 ($0.72) per share, with a total value of £16,500 ($21,478.78). Insiders purchased a total of 113,446 shares of company stock valued at $6,542,582 over the last 90 days. 4.36% of the stock is owned by company insiders.
Dr. Martens Company Profile
Dr. Martens plc designs, develops, procures, markets, sells, and distributes footwear in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It offers originals, fusion, kids, and casual, as well as accessories. The company offers its products under the Dr. Martens brand name. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom.
Further Reading
- Five stocks we like better than Dr. Martens
- Stock Analyst Ratings and Canadian Analyst Ratings
- Dot Ai IPO: CEO Ed Nabrotzky Shares Vision for Logistics Future
- Using the MarketBeat Stock Split Calculator
- The Hottest Markets to Watch After the Fed’s 25 Bps Rate Cut
- Using the MarketBeat Dividend Yield Calculator
- The Top 5 Performing S&P 500 Stocks YTD in 2024
Receive News & Ratings for Dr. Martens Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dr. Martens and related companies with MarketBeat.com's FREE daily email newsletter.
